How much funding has Click Therapeutics raised?

Click Therapeutics has raised $102.0M in total funding, most recently a Series C round.

Who are Click Therapeutics's investors?

Click Therapeutics's investors include Dassault Systèmes, Boehringer Ingelheim Venture Fund, H.I.G. BioHealth Partners, Accelmed Partners, Sanofi Ventures.

When was Click Therapeutics founded?

Click Therapeutics was founded in 2012.

Where is Click Therapeutics headquartered?

Click Therapeutics is headquartered in New York, New York, United States.

What industry is Click Therapeutics in?

Click Therapeutics operates in Digital Health, Therapeutics.

How many employees does Click Therapeutics have?

Click Therapeutics has 51-200 employees.

Click Therapeutics

Where Science Meets Software

New York, United States · Founded 2012 · $102.0M raised

Digital Health

Therapeutics

Headquarters: New York, New York
Employees: 51–200
Founded: 2012
Business Model: B2B2C

Website: clicktherapeutics.com
Total Funding: $102.0M
Last Round: $50.0M Series CApr 2026
Rounds: 3

About

Click Therapeutics develops, validates, and commercializes prescription digital therapeutics — software-based treatments for people with unmet medical needs including schizophrenia, opioid use disorder, insomnia, and acute coronary syndrome. Founded in 2012 by CEO David Benshoof Klein, the company operates at the intersection of neuroscience and software, creating a clinically validated modality called Digital Therapeutics™.

Summary

Click Therapeutics is a Digital Health company based in New York, United States, founded in 2012. It has raised $102.0M in total across 3 rounds, most recently a $50.0M Series C round in Apr 2026. Investors include Dassault Systèmes, Boehringer Ingelheim Venture Fund and H.I.G. BioHealth Partners.

LinkedIn X (Twitter)